Salicylaldehyde imine transition metal catalyst is a kind of olefin polymerization catalyst that is widely used in the coordination of salicylaldehyde imine ligand and pre-transition metal. Salicylaldehyde imine ligands have the characteristic of easily inserting different substituents via organic synthesis. Therefore, the regulation of the polymerization activity, polymerization product, and product distribution can be achieved by changing the steric hindrance effect, the electronic effect, and the number of metal active sites near the catalytic active center. The development status of the transition metal catalyst of salicylaldehyde imide was summarized in this paper. The influence of the ligand structure of the salicylaldehyde imide transition metal catalyst on the catalytic performance, which involved the high selectivity of ethylene trimerization, ethylene/α-olefin, polar monomer copolymerization, ethylene polymerization production, ultra-high molecular weight polyethylene, and many other areas of olefin polymerization, was elaborated, providing references for further study and industrial applications of this catalyst.

Clinical/methodological problem: The identification of clinically significant prostate carcinomas while avoiding overdiagnosis of low-malignant tumors is a challenge in routine clinical practice. Standard radiologic procedures: Multiparametric magnetic resonance imaging (MRI) of the prostate acquired and interpreted according to PI-RADS (Prostate Imaging Reporting and Data System Guidelines) is accepted as a clinical standard among urologists and radiologists. Methodological innovations: The PI-RADS guidelines have been newly updated to version 2.1 and, in addition to more precise technical requirements, include individual changes in lesion assessment. Performance: The PI-RADS guidelines have become crucial in the standardization of multiparametric MRI of the prostate and provide templates for structured reporting, facilitating communication with the referring physician. Evaluation: The guidelines, now updated to version 2.1, represent a refinement of the widely used version 2.0. Many aspects of reporting have been clarified, but some previously known limitations remain and require further improvement of the guidelines in future versions.